LRG1, as well as tumor size, serum AFP level, tumor multiplicity, clinical stage, vascular invasion, and tumor differentiation were shown to be responsible for the outcome of overall survival in both training cohort and validation cohort (Supplementary Table S2). This evidence concerns the gene AFP and neoplasm.